PMID: 7011223Mar 1, 1981Paper

Use of peroperative cefoxitin to prevent infection after colonic and rectal surgery

Annals of Surgery
C E HoffmannJ M Watts

Abstract

A double-blind, controlled trial was performed to assess the effect of a short intraoperative course of Cefoxitin, a new broad spectrum cephamycin antibiotic, on the incidence of septic complications following elective colonic and rectal surgery. In addition to a two-day preoperative bowel preparation, patients entered in the study received a short course of either Cefoxitin (three 2g intravenous bolus doses at two-hour intervals, the first before skin incision) or a matching placebo. Thirty-two patients received Cefoxitin and 33 patients received the placebo. Postoperative abdominal wound infections developed in one (3%) of the Cefoxitin-treated patients and nine (27%) of the placebo-treated patients. This difference is statistically significant (p = 0.01). Septic complications remote from the abdominal wound, e.g. intra-abdominal abscesses, occurred in both Cefoxitin-treated and placebo-treated patients, but numbers were too small for meaningful analysis. The study shows that even a very short peroperative course of Cefoxitin is highly effective in reducing postoperative abdominal wound infections after elective colorectal surgery.

References

Jul 2, 1977·Lancet·R S FeathersP Noone
Jul 1, 1978·The Journal of Antimicrobial Chemotherapy·C van Winzum
Jul 1, 1976·The British Journal of Surgery·M R KeighleyJ Alexander-Williams
Jul 1, 1977·Diseases of the Colon and Rectum·R DowningM R Keighley
Sep 1, 1969·The British Journal of Surgery·M T EverettJ Nettleton

❮ Previous
Next ❯

Citations

Oct 13, 2001·Diseases of the Colon and Rectum·O ZmoraS D Wexner
Mar 1, 1986·Diseases of the Colon and Rectum·M N de la Hunt, S J Karran
Feb 17, 2009·Surgical Infections·Donald E Fry
Mar 7, 2013·Surgical Infections·Dale W BratzlerUNKNOWN Society for Healthcare Epidemiology of America (SHEA)
Nov 20, 2008·Techniques in Coloproctology·A F J de BruinE van der Harst
Jan 1, 1997·AORN Journal·J D Butts, E T Wolford
May 13, 2014·The Cochrane Database of Systematic Reviews·Richard L NelsonMarija Barbateskovic
Feb 27, 2010·Journal of Biomedical Materials Research. Part a·Guruprakash SubbiahdossRoel Kuijer
Sep 1, 1988·The Australian and New Zealand Journal of Surgery·J C HallS M Gibb
Oct 1, 1990·Hospital Practice·I Brook
Sep 1, 1984·Pharmacotherapy·T G Burnakis
Feb 1, 1990·Diseases of the Colon and Rectum·J A Solla, D A Rothenberger
Mar 1, 1985·Drug Intelligence & Clinical Pharmacy·R P Rapp, D Blue
Feb 1, 1983·Current Problems in Surgery·J T DipiroW O Griffen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.